Annual EBITDA
-$47.29 M
-$15.47 M-48.60%
December 31, 2021
Summary
- As of February 10, 2025, ALNA annual EBITDA is -$47.29 million, with the most recent change of -$15.47 million (-48.60%) on December 31, 2021.
- During the last 3 years, ALNA annual EBITDA has fallen by -$11.77 million (-33.14%).
Performance
ALNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$8.20 M
+$3.24 M+28.32%
June 30, 2022
Summary
- As of February 10, 2025, ALNA quarterly EBITDA is -$8.20 million, with the most recent change of +$3.24 million (+28.32%) on June 30, 2022.
- Over the past year, ALNA quarterly EBITDA has increased by +$5.44 million (+39.89%).
Performance
ALNA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$41.95 M
+$5.44 M+11.48%
June 30, 2022
Summary
- As of February 10, 2025, ALNA TTM EBITDA is -$41.95 million, with the most recent change of +$5.44 million (+11.48%) on June 30, 2022.
- Over the past year, ALNA TTM EBITDA has increased by +$525.00 thousand (+1.24%).
Performance
ALNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ALNA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -48.6% | +39.9% | +1.2% |
| 3 y3 years | -33.1% | +27.4% | +10.3% |
| 5 y5 years | -126.5% | -83.9% | +10.3% |
ALNA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | +39.5% | at high | +13.0% |
| 5 y | 5-year | +48.6% | at low | +20.0% | +66.3% | +31.8% | +13.0% |
| alltime | all time | +242.5% | at low | +88.8% | +66.3% | +588.6% | +13.0% |
Allena Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$8.20 M(-28.3%) | -$41.95 M(-11.5%) |
| Mar 2022 | - | -$11.44 M(+14.8%) | -$47.39 M(+0.2%) |
| Dec 2021 | -$47.29 M(+48.6%) | -$9.96 M(-19.3%) | -$47.29 M(+0.7%) |
| Sep 2021 | - | -$12.35 M(-9.5%) | -$46.94 M(+10.5%) |
| Jun 2021 | - | -$13.64 M(+20.3%) | -$42.47 M(+19.1%) |
| Mar 2021 | - | -$11.34 M(+17.9%) | -$35.67 M(+12.1%) |
| Dec 2020 | -$31.82 M(-31.9%) | -$9.62 M(+22.0%) | -$31.82 M(-3.1%) |
| Sep 2020 | - | -$7.88 M(+15.4%) | -$32.85 M(-14.1%) |
| Jun 2020 | - | -$6.83 M(-8.8%) | -$38.26 M(-10.4%) |
| Mar 2020 | - | -$7.49 M(-29.6%) | -$42.73 M(-8.6%) |
| Dec 2019 | -$46.76 M | -$10.65 M(-19.9%) | -$46.76 M(+2.0%) |
| Sep 2019 | - | -$13.30 M(+17.7%) | -$45.86 M(+8.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$11.30 M(-1.9%) | -$42.25 M(+8.1%) |
| Mar 2019 | - | -$11.52 M(+18.2%) | -$39.08 M(+10.0%) |
| Dec 2018 | -$35.52 M(+70.1%) | -$9.75 M(+0.6%) | -$35.52 M(+9.9%) |
| Sep 2018 | - | -$9.69 M(+19.2%) | -$32.32 M(+19.8%) |
| Jun 2018 | - | -$8.13 M(+2.2%) | -$26.98 M(+15.7%) |
| Mar 2018 | - | -$7.95 M(+21.4%) | -$23.31 M(+11.6%) |
| Dec 2017 | -$20.88 M(-13.5%) | -$6.55 M(+50.8%) | -$20.88 M(+2.8%) |
| Sep 2017 | - | -$4.34 M(-2.6%) | -$20.31 M(-7.9%) |
| Jun 2017 | - | -$4.46 M(-19.3%) | -$22.06 M(+25.3%) |
| Mar 2017 | - | -$5.53 M(-7.7%) | -$17.60 M(+45.7%) |
| Dec 2016 | -$24.14 M(+74.8%) | -$5.99 M(-1.7%) | -$12.08 M(+98.3%) |
| Sep 2016 | - | -$6.09 M | -$6.09 M |
| Dec 2015 | -$13.81 M | - | - |
FAQ
- What is Allena Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Allena Pharmaceuticals?
- What is Allena Pharmaceuticals annual EBITDA year-on-year change?
- What is Allena Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Allena Pharmaceuticals?
- What is Allena Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Allena Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Allena Pharmaceuticals?
- What is Allena Pharmaceuticals TTM EBITDA year-on-year change?
What is Allena Pharmaceuticals annual EBITDA?
The current annual EBITDA of ALNA is -$47.29 M
What is the all time high annual EBITDA for Allena Pharmaceuticals?
Allena Pharmaceuticals all-time high annual EBITDA is -$13.81 M
What is Allena Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, ALNA annual EBITDA has changed by -$15.47 M (-48.60%)
What is Allena Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of ALNA is -$8.20 M
What is the all time high quarterly EBITDA for Allena Pharmaceuticals?
Allena Pharmaceuticals all-time high quarterly EBITDA is -$4.34 M
What is Allena Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, ALNA quarterly EBITDA has changed by +$5.44 M (+39.89%)
What is Allena Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of ALNA is -$41.95 M
What is the all time high TTM EBITDA for Allena Pharmaceuticals?
Allena Pharmaceuticals all-time high TTM EBITDA is -$6.09 M
What is Allena Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, ALNA TTM EBITDA has changed by +$525.00 K (+1.24%)